Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC
A prospective cohort study is evaluating neoadjuvant therapy with the PD-1 inhibitor sintilimab plus chemotherapy for resectable esophageal …
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study
Clinical trial update about a neoadjuvant chemotherapy-immunotherapy study for resectable esophageal squamous cell carcinoma. The trial is c…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating short-course radiotherapy plus sintilimab as neoadjuvant therapy for esophageal squamous cell carcinoma; the study …
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase II trial evaluating different radiotherapy doses in combination with sintilimab for locally advanced esophageal squamous cell carcinom…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC. [Phase 2]
Phase 2 clinical trial evaluating adebrelimab in combination with apatinib and chemotherapy/chemoradiotherapy for immuno-experienced second-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2024-06-18Clinical Trial Update: A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial is studying sintilimab in combination with chemotherapy as neoadjuvant treatment for esophageal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining a PD-1 inhibitor (sintilimab) with radiotherapy and immunonutrition for locall…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma [NA]
A clinical trial update showing enrollment by invitation for Cytosponge as surveillance after endoscopic submucosal dissection in esophageal…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating neoadjuvant Cadonilimab in combination with Anlotinib for locally advanced resectable esophageal squa…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma [NA]
This clinical trial compares chemoradiotherapy versus esophagectomy after endoscopic resection for superficial esophageal squamous cell carc…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Phase II Study of CRT Combined With QL1706 in ESCC Patients [Phase 2]
A Phase II clinical trial is evaluating the combination of CRT with QL1706 in patients with Esophageal Squamous Cell Carcinoma and is curren…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
Clinical update for a trial of short-course hypofractionated radiotherapy combined with raltitrexed and tislelizumab in esophageal squamous …
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Early Detection of Esophageal Squamous Cancer With the Capsule Sponge Device [NA]
This ClinicalTrials.gov entry details a study evaluating a Capsule Sponge device for early detection of esophageal squamous cell carcinoma, …
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC [Phase 2]
Phase 2 trial evaluating neoadjuvant immunotherapy combined with chemotherapy for locally advanced esophageal squamous cell carcinoma has co…
-
CLINICAL_TRIALS other · 2024-05-14Clinical Trial Update: Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma
A clinical trial evaluating multimodal endoscopic image fusion to assess infiltration in superficial esophageal squamous cell carcinoma; rec…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Changhai Multimodal Esophageal Cancer Cohort
A clinical trial update shows that the Changhai Multimodal Esophageal Cancer Cohort (NCT06410677) focusing on Esophageal Squamous Cell Carci…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial investigating nimotuzumab concurrently with chemoradiotherapy for unresectable esophageal squamous cell carcinoma is …
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer [Phase 2]
This is a Phase II clinical trial listing for Epigallocatechin-3-gallate in patients with esophageal squamous cell carcinoma, currently recr…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial evaluating toripalimab with paclitaxel and cisplatin vs. placebo with the same chemotherapy in advanced or metastatic esophage…
-
CLINICAL_TRIALS other · 2024-05-02Clinical Trial Update: Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor [Phase 3]
A Phase 3 clinical trial evaluating local therapy with a PD-1 inhibitor for esophageal squamous cell carcinoma with oligometastatic disease …
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma [Phase 4]
A Phase 4 clinical trial is evaluating serplulimab in combination with nab-paclitaxel and cisplatin as neoadjuvant therapy for resectable es…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data
A clinical trial evaluating a deep neural network analysis of NBI endoscopy data to accurately diagnose invasion depth in esophageal squamou…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Multiorgan Metabolic Imaging Response Assessment of Abemaciclib [Phase 2]
Phase 2 trial update evaluating multiorgan metabolic imaging response assessment of abemaciclib.
-
CLINICAL_TRIALS research · 2024-03-12Clinical Trial Update: Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]
A neoadjuvant chemoradiotherapy regimen is being explored followed by sequential immunotherapy in thoracic esophageal squamous cell carcinom…